...
ibo-img

Impact BioMedical, Inc., Common Stock

IBO

ASQ

$2.075

-$0.18

(-7.96%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$26.00M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
22.6
Volume info-icon
This is the total number of shares traded during the most recent trading day.
9.78K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.22 L
$3.25 H
$2.075

About Impact BioMedical, Inc., Common Stock

Impact BioMedical Inc. focused on discovery, development, and commercialization of products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use in as health supplements and medications. Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameIBOSectorS&P500
1-Week Return-4.64%-3.39%0.2%
1-Month Return-25.66%-1.92%2.72%
3-Month Return-3%-10.54%7.31%
6-Month Return-15.67%-4.47%10.44%

Financials

Dec '19Dec '21Dec '22Dec '23
Total Revenue-50.00K50.00K-[{"date":"2019-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses523.71K3.45M3.45M4.03M[{"date":"2019-12-31","value":13,"profit":true},{"date":"2021-12-31","value":85.75,"profit":true},{"date":"2022-12-31","value":85.75,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(523.71K)(3.40M)(3.40M)(4.03M)[{"date":"2019-12-31","value":-52370500,"profit":false},{"date":"2021-12-31","value":-340400000,"profit":false},{"date":"2022-12-31","value":-340400000,"profit":false},{"date":"2023-12-31","value":-402800000,"profit":false}]
Total Non-Operating Income/Expense-(4.47M)(4.47M)(379.00K)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-447200000,"profit":false},{"date":"2022-12-31","value":-447200000,"profit":false},{"date":"2023-12-31","value":-37900000,"profit":false}]
Pre-Tax Income(654.02K)(7.88M)(7.88M)(4.41M)[{"date":"2019-12-31","value":-65402000,"profit":false},{"date":"2021-12-31","value":-787600000,"profit":false},{"date":"2022-12-31","value":-787600000,"profit":false},{"date":"2023-12-31","value":-440700000,"profit":false}]
Income Taxes----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(654.02K)(7.25M)(7.25M)(4.41M)[{"date":"2019-12-31","value":-65402000,"profit":false},{"date":"2021-12-31","value":-725500000,"profit":false},{"date":"2022-12-31","value":-725500000,"profit":false},{"date":"2023-12-31","value":-440700000,"profit":false}]
Income From Discontinued Operations----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(454.44K)(7.05M)(7.05M)(4.34M)[{"date":"2019-12-31","value":-45443600,"profit":false},{"date":"2021-12-31","value":-705100000,"profit":false},{"date":"2022-12-31","value":-705100000,"profit":false},{"date":"2023-12-31","value":-433600000,"profit":false}]
EPS (Diluted)----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

IBO
Current Ratio 0.02

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

IBO
ROA (LTM) -4.99%
ROE (LTM) 3.45%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

IBO
Debt Ratio Lower is generally better. Negative is bad. 0.40
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.53

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

IBO
Trailing PE 22.60
Forward PE NM
P/S (TTM) 0.00
P/B 0.85
Price/FCF NM
EV/R 0.00
EV/Ebitda 10.21

FAQs

What is Impact BioMedical, Inc. share price today?

Impact BioMedical, Inc. (IBO) share price today is $2.075

Can Indians buy Impact BioMedical, Inc. shares?

Yes, Indians can buy shares of Impact BioMedical, Inc. (IBO) on Vested. To buy Impact BioMedical, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IBO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Impact BioMedical, Inc. be purchased?

Yes, you can purchase fractional shares of Impact BioMedical, Inc. (IBO) via the Vested app. You can start investing in Impact BioMedical, Inc. (IBO) with a minimum investment of $1.

How to invest in Impact BioMedical, Inc. shares from India?

You can invest in shares of Impact BioMedical, Inc. (IBO) via Vested in three simple steps:

  • Click on Sign Up or Invest in IBO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Impact BioMedical, Inc. shares
What is Impact BioMedical, Inc. 52-week high and low stock price?

The 52-week high price of Impact BioMedical, Inc. (IBO) is $3.25. The 52-week low price of Impact BioMedical, Inc. (IBO) is $1.22.

What is Impact BioMedical, Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Impact BioMedical, Inc. (IBO) is 22.6

What is Impact BioMedical, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Impact BioMedical, Inc. (IBO) is 0.85

What is Impact BioMedical, Inc. dividend yield?

The dividend yield of Impact BioMedical, Inc. (IBO) is 0.00%

What is the Market Cap of Impact BioMedical, Inc.?

The market capitalization of Impact BioMedical, Inc. (IBO) is $26.00M

What is Impact BioMedical, Inc.’s stock symbol?

The stock symbol (or ticker) of Impact BioMedical, Inc. is IBO

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top